Skip to content
10-Q

Quarterly Report

REMEDENT, INC.

0001144204-18-059981

← back to feed
Filed
Nov 14, 2018 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2019 · Nov 14, 2018 20M sh
Cash And Equivalents Q2 2019 · Sep 30, 2018 $55.12K
Cash And Equivalents Q2 2019 · Mar 31, 2018 $92.88K
Cash And Equivalents Q2 2019 · Sep 30, 2017 $88.81K
Cash And Equivalents Q2 2019 · Mar 31, 2017 $147.11K
Stockholders Equity Q2 2019 · Sep 30, 2018 $3.01M
Stockholders Equity Q2 2019 · Mar 31, 2018 $3.23M
Current Liabilities Q2 2019 · Sep 30, 2018 $2.16M
Current Liabilities Q2 2019 · Mar 31, 2018 $2.13M
Current Assets Q2 2019 · Sep 30, 2018 $1.42M
Current Assets Q2 2019 · Mar 31, 2018 $1.67M
Total Assets Q2 2019 · Sep 30, 2018 $5.25M
Total Assets Q2 2019 · Mar 31, 2018 $5.44M
Shares Diluted Q2 2019 · Sep 30, 2017 20M sh
Shares Diluted Q2 2019 · Sep 30, 2017 20M sh
Operating Cash Flow restated Q2 2019 · Sep 30, 2017 $1.95K
Eps Diluted Q2 2019 · Sep 30, 2017 $0.00
Eps Diluted Q2 2019 · Sep 30, 2017 $0.01
Eps Basic Q2 2019 · Sep 30, 2017 $0.00
Eps Basic Q2 2019 · Sep 30, 2017 $0.01
Sga Expense Q2 2019 · Sep 30, 2017 $262.29K
Sga Expense Q2 2019 · Sep 30, 2017 $447.8K
Rd Expense Q2 2019 · Sep 30, 2017 $221
Rd Expense Q2 2019 · Sep 30, 2017 $1.86K
Net Income Q2 2019 · Sep 30, 2017 $49.73K
Net Income Q2 2019 · Sep 30, 2017 $112.16K
Operating Income Q2 2019 · Sep 30, 2017 −$46.25K
Operating Income Q2 2019 · Sep 30, 2017 −$39.02K
Gross Profit Q2 2019 · Sep 30, 2017 $480.99K
Gross Profit Q2 2019 · Sep 30, 2017 $939.16K
Cost Of Revenue Q2 2019 · Sep 30, 2017 $197.7K
Cost Of Revenue Q2 2019 · Sep 30, 2017 $530.87K
Revenue Q2 2019 · Sep 30, 2017 $678.69K
Revenue Q2 2019 · Sep 30, 2017 $1.47M